Currently, semaglutide is only listed on the PBS for treatment of T2DM when certain conditions are met
Evidence From Preclinical and Clinical Studies Animal models have provided perhaps the most compelling data to date: multiple studies have demonstrated that GLP-1 receptor agonists reduce alcohol consumption, relapse-like drinking, and alcohol-induced neuroinflammation (Vallf et al., 2019
Specifically, IL-1 is constitutively produced and retained in keratinocytes, but in response to several stimuli, IL-1 is released, which is essentially a primary event of inflammation
Time matters
More than half of doctors surveyed have undergone MCED testing or recommend it to patients
Most do not, but doctors recommend early treatment to prevent the development of squamous cell skin cancer